A frameshift and several nonsense heterozygous mutations found in the cancer genomic database (Figure 7—source data 4) could downregulate cellular Arl15 protein level and reduce the normal TGFβ signaling activity, as shown by our Arl15 knockdown experiment (Figure 6b; Figure 6—figure supplement 1d). The gene discussed is ARL15; the disease is cancer.